ARTICLE | Clinical News
SD Pharma preclinical data
January 2, 2006 8:00 AM UTC
In a mouse model of sarcoma, SDP-014 was equivalent or slightly better than Taxotere docetaxel in reducing tumor burden with no immunogenicity, detectable hemolysis and vein irritation. SDP-014 is a ...